- Home
- ACNB vs RCKT Comparison
ACNB vs RCKT Comparison
Compare ACNB & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ACNB | RCKT |
|---|---|---|
| Founded | 1857 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 468.6M | 428.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ACNB | RCKT |
|---|---|---|
| Price | $49.04 | $3.76 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 14 |
| Target Price | ★ $49.50 | $29.12 |
| AVG Volume (30 Days) | 24.0K | ★ 2.2M |
| Earning Date | 01-22-2026 | 02-26-2026 |
| Dividend Yield | ★ 3.10% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.60 | N/A |
| Revenue | ★ $146,684,000.00 | N/A |
| Revenue This Year | $11.71 | N/A |
| Revenue Next Year | $2.43 | N/A |
| P/E Ratio | $13.62 | ★ N/A |
| Revenue Growth | ★ 32.02 | N/A |
| 52 Week Low | $35.70 | $2.19 |
| 52 Week High | $53.41 | $11.45 |
Technical Indicators
Market Signals| Indicator | ACNB | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 48.56 | 54.05 |
| Support Level | $48.28 | $3.43 |
| Resistance Level | $50.89 | $3.96 |
| Average True Range (ATR) | 1.46 | 0.24 |
| MACD | 0.14 | -0.01 |
| Stochastic Oscillator | 47.58 | 46.77 |
Price Performance
Historical ComparisonAbout ACNB ACNB Corporation
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.